Literature DB >> 31548243

Visit-to-Visit Fasting Glucose Variability in Young Adulthood and Hippocampal Integrity and Volume at Midlife.

Zhenyu Xiong1,2, Jiaying Li3, Xiangbin Zhong1,2, Shaozhao Zhang1,2, Xiuting Sun1,2, Huimin Zhou1,2, Yunzhi Chen4, Xiaodong Zhuang5,2,6, Xinxue Liao7,2.   

Abstract

OBJECTIVE: To determine whether visit-to-visit fasting glucose (VVFG) variability in young adulthood is associated with midlife hippocampal integrity and volume. RESEARCH DESIGN AND METHODS: Multivariable-adjusted linear regression models were used to estimate the association between VVFG variability and brain MRI variables in 543 CARDIA study participants. VVFG variability was defined by the SD of FG (SDFG), the coefficient of variation of the mean FG (CVFG), and the average real variability (ARVFG) over 25 years of follow-up. Hippocampal integrity fractional anisotropy (FA) and tissue volume standardized to intracranial volume were measured by 3T MRI at year 25.
RESULTS: After multivariable adjustment, higher FG variability (1-SD increase) was associated with lower hippocampal FA (SDFG -0.015 [95% CI -0.026, -0.004]; CVFG -0.009 [95% CI -0.018, -0.001]; ARVFG -0.011 [95% CI -0.019, -0.002]) and lower hippocampal volume (SDFG -0.012 [95% CI -0.023, -0.001]).
CONCLUSIONS: Higher VVFG variability in young adulthood is associated with lower midlife hippocampal integrity and volume, suggesting its value in predicting risk for hippocampal structural damage.
© 2019 by the American Diabetes Association.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31548243      PMCID: PMC7364671          DOI: 10.2337/dc19-0834

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   17.152


  14 in total

1.  Effect of glucagon-like peptide-1 analogue; Exendin-4, on cognitive functions in type 2 diabetes mellitus; possible modulation of brain derived neurotrophic factor and brain Visfatin.

Authors:  O M Abdelwahed; O M Tork; M M Gamal El Din; L Rashed; M Zickri
Journal:  Brain Res Bull       Date:  2018-02-05       Impact factor: 4.077

Review 2.  4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes-2019.

Authors: 
Journal:  Diabetes Care       Date:  2019-01       Impact factor: 19.112

3.  Intimal-medial thickness of the carotid artery in nondiabetic and NIDDM patients. Relationship with insulin resistance.

Authors:  E Bonora; R Tessari; R Micciolo; M Zenere; G Targher; R Padovani; G Falezza; M Muggeo
Journal:  Diabetes Care       Date:  1997-04       Impact factor: 19.112

4.  Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes.

Authors:  Louis Monnier; Emilie Mas; Christine Ginet; Françoise Michel; Laetitia Villon; Jean-Paul Cristol; Claude Colette
Journal:  JAMA       Date:  2006-04-12       Impact factor: 56.272

5.  Increasing severity of cardiovascular risk factors with increasing middle cerebral artery stenotic involvement in type 2 diabetic Chinese patients with asymptomatic cerebrovascular disease.

Authors:  G Neil Thomas; Jian Wen Lin; Wynnie W M Lam; Brian Tomlinson; Vincent Yeung; Juliana C N Chan; Roxanna Liu; Ka Sing Wong
Journal:  Diabetes Care       Date:  2004-05       Impact factor: 19.112

6.  Relations of arterial stiffness and endothelial function to brain aging in the community.

Authors:  Connie W Tsao; Sudha Seshadri; Alexa S Beiser; Andrew J Westwood; Charles Decarli; Rhoda Au; Jayandra J Himali; Naomi M Hamburg; Joseph A Vita; Daniel Levy; Martin G Larson; Emelia J Benjamin; Philip A Wolf; Ramachandran S Vasan; Gary F Mitchell
Journal:  Neurology       Date:  2013-08-09       Impact factor: 9.910

7.  Effects of fluctuating glucose levels on neuronal cells in vitro.

Authors:  Vincenzo C Russo; Sandra Higgins; George A Werther; Fergus J Cameron
Journal:  Neurochem Res       Date:  2012-05-08       Impact factor: 3.996

8.  Fasting Glucose Variability in Young Adulthood and Cognitive Function in Middle Age: The Coronary Artery Risk Development in Young Adults (CARDIA) Study.

Authors:  Michael P Bancks; Mercedes R Carnethon; David R Jacobs; Lenore J Launer; Jared P Reis; Pamela J Schreiner; Ravi V Shah; Stephen Sidney; Kristine Yaffe; Yuichiro Yano; Norrina B Allen
Journal:  Diabetes Care       Date:  2018-10-10       Impact factor: 19.112

9.  Nondiabetic Glucometabolic Status and Progression of Aortic Stiffness: The Whitehall II Study.

Authors:  Carmel M McEniery; Ian B Wilkinson; Nanna B Johansen; Daniel R Witte; Archana Singh-Manoux; Mika Kivimaki; Adam G Tabak; Eric J Brunner; Martin J Shipley
Journal:  Diabetes Care       Date:  2017-01-25       Impact factor: 19.112

10.  Central pulse pressure and its hemodynamic determinants in middle-aged adults with impaired fasting glucose and diabetes: the Asklepios study.

Authors:  Julio A Chirinos; Patrick Segers; Thierry C Gillebert; Marc L De Buyzere; Caroline M Van Daele; Zubair A Khan; Umair Khawar; Dirk De Bacquer; Ernst R Rietzschel
Journal:  Diabetes Care       Date:  2013-04-22       Impact factor: 19.112

View more
  2 in total

1.  Relationship of fasting glucose and longitudinal Alzheimer's disease imaging markers.

Authors:  Robyn A Honea; Casey S John; Zachary D Green; Paul J Kueck; Matthew K Taylor; Rebecca J Lepping; Ryan Townley; Eric D Vidoni; Jeffery M Burns; Jill K Morris
Journal:  Alzheimers Dement (N Y)       Date:  2022-02-01

2.  Long-term tracking of fasting blood glucose variability and peripheral artery disease in people without diabetes.

Authors:  Xiu-Ting Sun; Cheng Zeng; Shao-Zhao Zhang; Hui-Min Zhou; Xiang-Bin Zhong; Zhen-Yu Xiong; Da-Ya Yang; Yue Guo; Xiao-Dong Zhuang; Xin-Xue Liao
Journal:  BMJ Open Diabetes Res Care       Date:  2020-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.